Neomics Pharmaceuticals LLC
- Biotech or pharma, therapeutic R&D
3rd-generation Chimeric Antigen Receptor (CAR) transgene for improved CAR-T therapies.
Immune Checkpoint Switch (ICS) transgene to engineer T cells into effective cell therapies for solid tumors.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}